Harbor Investment Advisory LLC Has $557,000 Stake in Elevance Health, Inc. (NYSE:ELV)

Harbor Investment Advisory LLC reduced its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 20.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,510 shares of the company’s stock after selling 387 shares during the quarter. Harbor Investment Advisory LLC’s holdings in Elevance Health were worth $557,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ELV. Raelipskie Partnership acquired a new stake in shares of Elevance Health during the 3rd quarter valued at $26,000. PSI Advisors LLC purchased a new stake in shares of Elevance Health during the third quarter worth $27,000. Eastern Bank acquired a new stake in Elevance Health during the third quarter valued at $31,000. Dunhill Financial LLC grew its stake in Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares in the last quarter. Finally, Peterson Financial Group Inc. acquired a new position in Elevance Health in the 3rd quarter worth about $44,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a research note on Friday, January 17th. Argus lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Royal Bank of Canada cut their price target on shares of Elevance Health from $585.00 to $478.00 and set an “outperform” rating on the stock in a report on Friday, October 18th. Morgan Stanley lowered their target price on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 23rd. Finally, Cantor Fitzgerald reduced their price target on Elevance Health from $600.00 to $485.00 and set an “overweight” rating for the company in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average price target of $536.53.

Elevance Health Stock Up 1.1 %

Shares of ELV stock opened at $389.45 on Wednesday. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The firm has a market cap of $90.32 billion, a PE ratio of 14.20, a price-to-earnings-growth ratio of 1.09 and a beta of 0.84. The stock has a 50 day moving average of $387.20 and a 200-day moving average of $465.15.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.